These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28615716)
1. Lipid vesicles containing transferrin receptor binding peptide TfR-T Mu LM; Bu YZ; Liu L; Xie HJ; Ju RJ; Wu JS; Zeng F; Zhao Y; Zhang JY; Lu WL Sci Rep; 2017 Jun; 7(1):3487. PubMed ID: 28615716 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells. Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055 [TBL] [Abstract][Full Text] [Related]
4. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma. Liu Y; Mei L; Yu Q; Xu C; Qiu Y; Yang Y; Shi K; Zhang Q; Gao H; Zhang Z; He Q ACS Appl Mater Interfaces; 2015 Aug; 7(30):16792-801. PubMed ID: 26173814 [TBL] [Abstract][Full Text] [Related]
5. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme. Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Li XT; Ju RJ; Li XY; Zeng F; Shi JF; Liu L; Zhang CX; Sun MG; Lou JN; Lu WL Oncotarget; 2014 Aug; 5(15):6497-511. PubMed ID: 25153726 [TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide-modified lipid vesicles: fabrication and use for the treatment of brain glioma. Wu JS; Mu LM; Bu YZ; Liu L; Yan Y; Hu YJ; Bai J; Zhang JY; Lu W; Lu WL Oncotarget; 2017 Jun; 8(25):40906-40921. PubMed ID: 28402948 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma. Li XT; Tang W; Xie HJ; Liu S; Song XL; Xiao Y; Wang X; Cheng L; Chen GR J Liposome Res; 2019 Mar; 29(1):21-34. PubMed ID: 29166813 [TBL] [Abstract][Full Text] [Related]
10. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells. Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164 [TBL] [Abstract][Full Text] [Related]
11. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles. Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123 [TBL] [Abstract][Full Text] [Related]
12. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. Wang Y; Ying X; Xu H; Yan H; Li X; Tang H Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885 [TBL] [Abstract][Full Text] [Related]
13. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma. Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496 [No Abstract] [Full Text] [Related]
14. Construction of Functional Targeting Daunorubicin Liposomes Used for Eliminating Brain Glioma and Glioma Stem Cells. Zhao WY; Zhang CX; Liu L; Mu LM; Zeng F; Ju RJ; Xie HJ; Yan Y; Zhao Y; Lu WL J Biomed Nanotechnol; 2016 Jul; 12(7):1404-420. PubMed ID: 29336535 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. Mojarad-Jabali S; Farshbaf M; Hemmati S; Sarfraz M; Motasadizadeh H; Shahbazi Mojarrad J; Atyabi F; Zakeri-Milani P; Valizadeh H Int J Pharm; 2022 Feb; 613():121395. PubMed ID: 34933080 [TBL] [Abstract][Full Text] [Related]
16. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063 [TBL] [Abstract][Full Text] [Related]
17. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475 [TBL] [Abstract][Full Text] [Related]
18. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG Song XL; Liu S; Jiang Y; Gu LY; Xiao Y; Wang X; Cheng L; Li XT Eur J Pharm Sci; 2017 Jan; 96():129-140. PubMed ID: 27644895 [TBL] [Abstract][Full Text] [Related]
19. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. Tian W; Ying X; Du J; Guo J; Men Y; Zhang Y; Li RJ; Yao HJ; Lou JN; Zhang LR; Lu WL Eur J Pharm Sci; 2010 Oct; 41(2):232-43. PubMed ID: 20600880 [TBL] [Abstract][Full Text] [Related]
20. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]